p38α stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis
暂无分享,去创建一个
Jonathan D Cooper | C. Shaw | P. Leigh | M. Ward | J. Cooper | A. Grierson | Christopher C. J. Miller | C. Dingwall | H. Byers | S. Banner | B. Anderton | Malcolm Ward | Christopher E Shaw | M. Perkinton | Andrew J Grierson | Steven Ackerley | Steven Banner | Michael S Perkinton | Janet Brownlees | Helen L Byers | Paul Thornhill | Kader Hussain | Jennifer S Waby | Brian H Anderton | Colin Dingwall | P.Nigel Leigh | Christopher C.J Miller | P. Thornhill | S. Ackerley | J. Brownlees | Jennifer S. Waby | Kader Hussain | C. Shaw
[1] M. Taoka,et al. In Vivo and in Vitro Phosphorylation at Ser-493 in the Glutamate (E)-segment of Neurofilament-H Subunit by Glycogen Synthase Kinase 3β* , 2002, The Journal of Biological Chemistry.
[2] D. Cleveland,et al. Slowing of axonal transport is a very early event in the toxicity of ALS–linked SOD1 mutants to motor neurons , 1999 .
[3] K. Ishiguro,et al. Tau protein kinase II has a similar characteristic to cdc2 kinase for phosphorylating neurofilament proteins. , 1993, Journal of Biological Chemistry.
[4] A. Grierson,et al. Axonal transport of neurofilaments in normal and disease states , 2002, Cellular and Molecular Life Sciences CMLS.
[5] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[6] C. Shaw,et al. Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. , 2002, Human molecular genetics.
[7] J. Julien,et al. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis , 1995, Nature.
[8] A. Hirano,et al. Fine Structural Observations of Neurofilamentous Changes in Amyotrophic Lateral Sclerosis , 1984, Journal of neuropathology and experimental neurology.
[9] J. Trojanowski,et al. Phosphorylated high molecular weight neurofilament protein in lower motor neurons in amyotrophic lateral sclerosis and other neurodegenerative diseases involving ventral horn cells , 2004, Acta Neuropathologica.
[10] D. Figlewicz,et al. Aggregation of Mutant Cu/Zn Superoxide Dismutase Proteins in a Culture Model of ALS , 1997, Journal of neuropathology and experimental neurology.
[11] Jiahuai Han,et al. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms , 1995, Science.
[12] S. Chin,et al. Transfected rat high-molecular-weight neurofilament (NF-H) coassembles with vimentin in a predominantly nonphosphorylated form , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[13] W. Blackstock,et al. Identification of Phosphorylation Sites on Neurofilament Proteins by Nanoelectrospray Mass Spectrometry* , 1997, The Journal of Biological Chemistry.
[14] M. Gurney,et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.
[15] C. Shaw,et al. Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3. , 2000, Journal of cell science.
[16] S. Chin,et al. Complete amino acid sequence and in vitro expression of rat NF-M, the middle molecular weight neurofilament protein , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[17] Betty Y. S. Kim,et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice , 2002, Nature.
[18] M. Gurney,et al. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[19] J. Julien,et al. Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor-α , 2001, The Journal of cell biology.
[20] P. Cohen,et al. Purification and cDNA cloning of SAPKK3, the major activator of RK/p38 in stress‐ and cytokine‐stimulated monocytes and epithelial cells. , 1996, The EMBO journal.
[21] L. Tsai,et al. Differential Cellular Phosphorylation of Neurofilament Heavy Side‐Arms by Glycogen Synthase Kinase‐3 and Cyclin‐Dependent Kinase‐5 , 1996, Journal of neurochemistry.
[22] J. H. Wang,et al. Brain proline-directed protein kinase is a neurofilament kinase which displays high sequence homology to p34cdc2. , 1992, The Journal of biological chemistry.
[23] M. Ward,et al. The neuronal adaptor protein Fe65 is phosphorylated by mitogen-activated protein kinase (ERK1/2) , 2003, Molecular and Cellular Neuroscience.
[24] J. Trojanowski,et al. Neurofilaments and Orthograde Transport Are Reduced in Ventral Root Axons of Transgenic Mice that Express Human SOD1 with a G93A Mutation , 1997, The Journal of cell biology.
[25] J. Kyriakis,et al. Tumor Necrosis Factor Signaling to Stress-activated Protein Kinase (SAPK)/Jun NH2-terminal Kinase (JNK) and p38 , 1998, The Journal of Biological Chemistry.
[26] C. Shaw,et al. Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments , 2003, The Journal of cell biology.
[27] B. Giasson,et al. Aberrant Stress-induced Phosphorylation of Perikaryal Neurofilaments* , 1996, The Journal of Biological Chemistry.
[28] Minh N. H. Nguyen,et al. Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice , 2003, Science.
[29] Simon Lovestone,et al. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells , 1994, Current Biology.
[30] J. Julien,et al. Multiple phosphorylation sites in mammalian neurofilament polypeptides. , 1982, The Journal of biological chemistry.
[31] R. Davis,et al. MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway , 1996, Molecular and cellular biology.
[32] C. Miller,et al. Phosphorylation of Neurofilament Heavy‐Chain Side‐Arm Fragments by Cyclin‐Dependent Kinase‐5 and Glycogen Synthase Kinase‐3α in Transfected Cells , 1997, Journal of neurochemistry.
[33] S. Pelech,et al. Protein kinase and protein phosphatase expression in the central nervous system of G93A mSOD over‐expressing mice , 2003, Journal of neurochemistry.
[34] J. Julien,et al. Minocycline Slows Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis , 2002, Neurobiology of Disease.
[35] D. Borchelt,et al. ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions , 1997, Neuron.
[36] D. Bredesen,et al. Altered Reactivity of Superoxide Dismutase in Familial Amyotrophic Lateral Sclerosis , 1996, Science.
[37] V. Lee,et al. Phosphate dependent and independent neurofilament epitopes in the axonal swellings of patients with motor neuron disease and controls. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[38] C. Rossi,et al. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression , 2003, Molecular and Cellular Neuroscience.
[39] J. Julien,et al. Deregulation of Cdk5 in a Mouse Model of ALS Toxicity Alleviated by Perikaryal Neurofilament Inclusions , 2001, Neuron.
[40] D. Borchelt,et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria , 1995, Neuron.
[41] Bingren Hu,et al. Immunolocalization of p38 MAP kinase in mouse brain , 2000, Brain Research.
[42] M. Gurney,et al. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[43] T. Shea,et al. Neurofilaments Consist of Distinct Populations That Can Be Distinguished by C-Terminal Phosphorylation, Bundling, and Axonal Transport Rate in Growing Axonal Neurites , 2001, The Journal of Neuroscience.
[44] H. Gainer,et al. Identification of Endogenously Phosphorylated KSP Sites in the High‐Molecular‐Weight Rat Neurofilament Protein , 1994, Journal of neurochemistry.
[45] J. Trojanowski,et al. Monoclonal antibodies distinguish several differentially phosphorylated states of the two largest rat neurofilament subunits (NF-H and NF-M) and demonstrate their existence in the normal nervous system of adult rats , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[46] R. Liem,et al. Phosphorylation of the High Molecular Weight Neurofilament Protein (NF-H) by Cdk5 and p35* , 1996, The Journal of Biological Chemistry.
[47] J. Morrison,et al. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[48] C. Shaw,et al. Glutamate Slows Axonal Transport of Neurofilaments in Transfected Neurons , 2000, The Journal of cell biology.
[49] A. Nebreda,et al. Reactivating Kinase/p38 Phosphorylates τ Protein In Vitro , 1997 .
[50] Robert H. Brown,et al. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter , 1999, Nature Neuroscience.
[51] Philip R. Cohen,et al. Activation of stress‐activated protein kinase‐3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38) , 1997, The EMBO journal.
[52] Veeranna,et al. Mitogen-Activated Protein Kinases (Erk1,2) Phosphorylate Lys-Ser-Pro (KSP) Repeats in Neurofilament Proteins NF-H and NF-M , 1998, The Journal of Neuroscience.
[53] M. Pericak-Vance,et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. , 1993, Science.
[54] L. Otvos,et al. Identification of the major multiphosphorylation site in mammalian neurofilaments. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[55] R. Nixon,et al. Phosphorylation on carboxyl terminus domains of neurofilament proteins in retinal ganglion cell neurons in vivo: influences on regional neurofilament accumulation, interneurofilament spacing, and axon caliber , 1994, The Journal of cell biology.
[56] S. Carpenter. Proximal axonal enlargement in motor neuron disease , 1968, Neurology.
[57] Ram K. Sihag,et al. Local Control of Neurofilament Accumulation during Radial Growth of Myelinating Axons in Vivo , 2000, The Journal of cell biology.
[58] M. Carson,et al. ALS, SOD and peroxynitrite , 1993, Nature.
[59] L. Sternberger,et al. Monoclonal antibodies distinguish phosphorylated and nonphosphorylated forms of neurofilaments in situ. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[60] Hiroshi Nishimune,et al. Motoneuron Death Triggered by a Specific Pathway Downstream of Fas Potentiation by ALS-Linked SOD1 Mutations , 2002, Neuron.
[61] J. Avruch,et al. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. , 2001, Physiological reviews.
[62] Guy A. Rouleau,et al. SOD1 mutation is assosiated with accumulation of neurofilaments in amyotrophic lateral scelaries , 1996 .
[63] J. K. Lee,et al. Constitutive activity and differential localization of p38α and p38β MAPKs in adult mouse brain , 2000, Journal of neuroscience research.
[64] T. Shea,et al. C-terminal phosphorylation of the high molecular weight neurofilament subunit correlates with decreased neurofilament axonal transport velocity , 2000, Brain Research.
[65] B. Giasson,et al. Study of Proline-Directed Protein Kinases Involved in Phosphorylation of the Heavy Neurofilament Subunit , 1997, The Journal of Neuroscience.
[66] J. Trojanowski,et al. Phosphorylated high molecular weight neurofilament protein in the peripheral motor, sensory and sympathetic neuronal perikarya: system-dependent normal variations and changes in amyotrophic lateral sclerosis and multiple system atrophy , 2004, Acta Neuropathologica.
[67] W. Robberecht,et al. Minocycline delays disease onset and mortality in a transgenic model of ALS , 2002, Neuroreport.
[68] H. Pant,et al. cdc2-like kinase from rat spinal cord specifically phosphorylates KSPXK motifs in neurofilament proteins: isolation and characterization. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[69] L. Bruijn,et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. , 1998, Science.